<DOC>
	<DOC>NCT02095444</DOC>
	<brief_summary>The purpose of this study is to determine whether human menstrual blood-derived stem cells are effective in the treatment of infection of H7N9 virus caused acute lung injury.</brief_summary>
	<brief_title>Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection</brief_title>
	<detailed_description>1. recruiting volunteers of H7N9 infection: age &gt; 18; patients signed with the informed consent; APACHE II &gt; 20 score 2. patients infused with menstrual blood progenitor cells infusion dose: 1~10Ã—10*7 cells/kg infusion frequency: 2 times a week, 2 weeks for infusion 3. test items and standard spirits lifted; pulmonary function improved; lung image injury improved</detailed_description>
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Multiple Organ Failure</mesh_term>
	<criteria>Clinical diagnosis of H7N9 infection must be critical injured for lung tissues cancer diseases pregnancy mental disorder allergic constitution severe inflammation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>